Delivery Order SPE2DE21D7020-SPE2D626F17B8
- Not listed
- Boston Scientific Corp has been awarded a delivery order by the Defense Health Agency's Medical Supply Chain for WALLSTENTS, with a fixed-price contract containing economic price adjustment provisions. The contract, valued at $10,455.54, is scheduled for completion by September 11, 2025, and represents a non-set-aside award. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures advanced cardiovascular and interventional medical...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $3,010.72 for wallstents under the Defense Health Agency's Medical Supply Chain program. The contract, awarded on August 11, 2025, with an ultimate completion date of August 18, 2025, utilizes fixed-price pricing with economic price adjustment. This delivery order represents part of Boston Scientific's broader federal portfolio, which encompasses...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $3,326.30 for enroute TCAR (transcarotid) stents under the Defense Health Agency's Medical Supply Chain program. The award, issued December 11, 2025, with an ultimate completion date of December 18, 2025, carries fixed-price pricing with economic price adjustment provisions and was made without a small business set-aside. The delivery order will be performed at Boston Scientific's...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $7,593.10 by the Defense Health Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 27, 2025. The contract involves the supply of enroute TCAR (transcarotid artery revascularization) stents, specialized cardiovascular intervention devices used in minimally invasive procedures. This delivery order was competitively awarded with no...
- Boston Scientific Corp has been awarded a delivery order valued at $8,699.73 for WALLSTENTS by the Defense Health Agency's Medical Supply Chain, a defense-focused federal entity responsible for supplying medical devices to the Department of Defense healthcare system. The contract, issued on August 6, 2025, with an ultimate completion date of August 13, 2025, is structured as a fixed-price agreement with economic price adjustment provisions. Performance will be conducted at Boston Scientific's...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order contract valued at $77,610.18 for the supply of ELUVIA US stents to the Department of Veterans Affairs, specifically through Veterans Integrated Service Network 22. This firm fixed-price delivery order, awarded on March 10, 2026, with an ultimate completion date of May 29, 2026, represents a continuation of Boston Scientific's extensive medical device supply relationship with the VA...
- Boston Scientific Corp was awarded a delivery order valued at $3,326.30 by the Defense Health Agency's Medical Supply Chain for enroute TCAR stents, with performance in Marlborough, MA. The contract was awarded on August 12, 2025, with an ultimate completion date of August 19, 2025, and utilizes fixed-price pricing with economic price adjustment. This is an open competition award with no set-aside designation, allowing Boston Scientific to compete directly against other qualified vendors in...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,426.17 under a Defense Health Agency Medical Supply Chain contract. The award, issued on December 12, 2025, is designated as "SUPER STIFF" and carries a fixed-price contract structure with economic price adjustment provisions. Performance is scheduled for completion by December 19, 2025, at the contractor's Marlborough, Massachusetts facility. This delivery order was...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $11,825 to Boston Scientific Corp for ELUVIA drug-eluting stents. The contract was awarded on August 8, 2025, with an ultimate completion date of August 15, 2025, and carries a fixed-price structure with economic price adjustment terms. This delivery order represents Boston Scientific's continued provision of advanced cardiovascular intervention devices to federal healthcare systems, with performance to be...
- Boston Scientific Corp has been awarded a delivery order valued at $4,550.54 for support catheters by the Defense Health Agency's Medical Supply Chain division. The contract, issued on November 6, 2025, utilizes a fixed-price pricing structure with economic price adjustment provisions and carries an ultimate completion date of November 14, 2025. This delivery order is being performed in Marlborough, Massachusetts, where Boston Scientific maintains its headquarters. No small business set-aside...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F17B8Delivery Order
Boston Scientific Corp was awarded a delivery order valued at $4,351.60 for a drug-eluting vascular stent (7mm x 100mm x 130cm) on December 12, 2025, with an ultimate completion date of December 19, 2025. This fixed-price delivery order with economic price adjustment was issued by the Defense Health Agency's Medical Supply Chain division and will be performed in Marlborough, Massachusetts. The award was made without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. This delivery order is issued against Boston Scientific's existing Blanket Purchase Agreement with the Defense Health Agency valued at $750,000 with a ceiling through March 30, 2030, which was established as a single-award indefinite delivery vehicle for specialized medical devices and radiation treatment technologies. Boston Scientific, a global medical technology company headquartered in Marlborough, Massachusetts, serves as a critical supplier to federal healthcare agencies including the Department of Defense and Veterans Affairs. The company maintains an extensive portfolio of federal contracts for advanced cardiovascular and interventional medical devices, including stents, guidewires, catheters, and related vascular intervention equipment. This particular delivery order reflects routine procurement of specialized vascular stent technology to support military healthcare facilities and Veterans Affairs medical centers, enabling the Defense Health Agency to maintain continuous supply chain access to Boston Scientific's drug-eluting stent technologies for patient care delivery across the defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 12/11/25 |